FDA expands acne treatment access while healthcare faces trust challenges; advances in early cancer detection, allergy research, and vaccine development offer new treatment options.

FDA approves over-the-counter switch for adapalene 0.1% and benzoyl peroxide 2.5% combination acne treatment, expanding access for patients 12 and older who previously required prescriptions since its 2008 approval.

Cambridge scientists develop injectable nanosensor detecting 'zombie' cell proteins in urine to identify lung cancer years before symptoms appear, with potential availability in GP surgeries within 5 years.

New mRNA-1010 vaccine demonstrates superior efficacy over standard-dose inactivated seasonal flu vaccine in older adults for preventing influenza-like illness in single-dose format.

Shared decision-making and improved communication emerge as key strategies for helping chronic pain and arthritis patients safely reduce or discontinue opioid medications.

Study reveals genital lesions as most common presentation of cutaneous Crohn's disease, with patients showing favorable responses to biologic therapy treatment.

Alternaria fungus sensitization in adolescence linked to increased persistent asthma and rhinitis risk, signaling need for early allergy detection and intervention.

Tree nut allergies affect nearly 6% of Dutch children aged 1-12 years, with research showing fewer than 1 in 4 children introduced to tree nuts before 12 months of age.

Nearly half of US physicians report patients are losing trust in their medical recommendations according to Medscape survey of 400 doctors, highlighting growing physician-patient communication challenges.